Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 13Colorectal Neoplasms 5Neoplasm Metastasis 4Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Solid Tumors Harboring a BRAF V600 Mutation 1Skin Neoplasms 1Skin Diseases 1Pancreatic Neoplasms 1Lymphatic Metastasis 1Hematologic Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Astrocytoma 1Advanced BRAF Mutant Cancers 1

Interventions

encorafenib 1binimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced BRAF Mutant Cancers × encorafenib × Clear all
NCT03843775 2024-10-21

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
17 enrolled 9 charts

Advanced BRAF Mutant Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡